| Amy Bertine Higgs, OTR/L | |
|
6262 Meacham Rd, Salem, VA 24153-8258 | |
| (540) 204-1099 | |
| Not Available |
| Full Name | Amy Bertine Higgs |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 6262 Meacham Rd, Salem, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326279381 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 0119004158 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amy Bertine Higgs, OTR/L 6262 Meacham Road, Salem, VA 24153 Ph: (540) 204-1099 | Amy Bertine Higgs, OTR/L 6262 Meacham Rd, Salem, VA 24153-8258 Ph: (540) 204-1099 |
News Archive
David H. Fater, CEO of Vicor Technologies, Inc., today announced that original research conducted using its PD2i algorithm to prospectively predict risk of sudden cardiac death was published in Therapeutics and Clinical Risk Management.
Affymax, Inc. today announced that it has received a $10 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize peginesatide (formerly known as Hematide™), Affymax's investigational drug for the treatment of anemia in chronic renal failure patients.
In four separate pivotal clinical studies presented on Friday, a greater percentage of moderate to severe chronic plaque psoriasis patients treated with briakinumab, Abbott's investigational IL-12/23 inhibitor (ABT-874), achieved 75 percent or better skin clearance rates than those treated with etanercept (Enbrel®), methotrexate or placebo. Abbott presented data from all briakinumab pivotal studies in psoriasis at the European Association of Dermatology and Venereology scientific sessions.
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped one treatment within a large, ongoing North American clinical trial of diabetes and cardiovascular disease 18 months early due to safety concerns after review of available data, although the study will continue.
A large registry analysis shows that younger people may be missing out on a general decline in mortality rates among patients with diabetes.
› Verified 2 days ago
Mrs. Christine Anne Mangone, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1970 Roanoke Blvd, Salem, VA 24153 Phone: 540-982-2463 Fax: 540-983-1038 | |
Autumn Hiduskey, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1970 Roanoke Blvd, Salem, VA 24153 Phone: 540-982-2463 | |
Mark Edward Realmuto, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1970 Roanoke Blvd, Salem, VA 24153 Phone: 540-982-2463 Fax: 540-983-5080 | |
Madison Branson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 844 Red Ln, Salem, VA 24153 Phone: 540-525-1866 | |
Emilie Thompson Ashworth, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3737 W Main St, Salem, VA 24153 Phone: 540-380-6520 | |
Christi L Nicely, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2001 Ridgewood Dr, Salem, VA 24153 Phone: 540-378-4120 Fax: 540-378-4121 | |
Kristen Gerteisen, MS,OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3737 W Main St, Salem, VA 24153 Phone: 540-380-6511 |